Holen Sie sich die Stockscreener-App
1.54
3.74%
-0.06
Schlusskurs vom Vortag:
$1.60
Offen:
$1.6
24-Stunden-Volumen:
52,963
Relative Volume:
0.14
Marktkapitalisierung:
$84.20M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.0764
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
-6.66%
1M Leistung:
+6.95%
6M Leistung:
-31.55%
1J Leistung:
-65.00%
1-Tages-Spanne:
$1.54
$1.60
1-Wochen-Bereich:
$1.52
$1.69
52-Wochen-Spanne:
$1.20
$6.10
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.5524 | 84.06M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.12 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
828.79 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Custom watchlist performance reports with Cibus Inc.Trade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Should you hold or exit Cibus Inc. now2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Heatmap analysis for Cibus Inc. and competitorsPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Will Cibus Inc. stock benefit from sector rotationPortfolio Gains Summary & Daily Price Action Insights - newser.com
Does Cibus Inc. fit your quant trading model2025 Short Interest & Daily Technical Stock Forecast Reports - newser.com
Identifying reversal signals in Cibus Inc.Weekly Investment Report & Fast Momentum Entry Tips - newser.com
Is Cibus Inc. stock supported by innovation pipelineMarket Growth Summary & Verified Entry Point Signals - newser.com
Why Cibus Inc. stock appeals to dividend seekersIndex Update & AI Enhanced Trading Alerts - newser.com
Applying chart zones and confluence areas to Cibus Inc.Buy Signal & Growth Oriented Trade Recommendations - newser.com
Will Cibus Inc. outperform the market2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Is Cibus Inc. stock reversal real or fakePortfolio Risk Report & Safe Entry Zone Tips - newser.com
Will Cibus Inc. stock deliver shareholder value2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Can you recover from losses in Cibus Inc.Weekly Investment Report & Fast Entry Momentum Alerts - newser.com
Is Cibus Inc. stock a safe buy before earningsBuy Signal & Reliable Volume Spike Trade Alerts - newser.com
How Cibus Inc. stock performs in stagflationQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
Cibus (CBUS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call - The Manila Times
Will Cibus Inc. rebound enough to break evenWeekly Volume Report & Entry Point Confirmation Signals - newser.com
Why Cibus Inc. stock remains a top recommendationJuly 2025 Trends & Weekly Top Performers Watchlists - Fundação Cultural do Pará
Cibus and AgVayā Partner to Boost Rice Productivity in India with Advanced Gene Editing Technology - global-agriculture.com
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):